person · Reporting owner

PUHY DOROTHY E

Disclosed activity across 4 companies

Tapewire entity: 38673
SEC CIK: 0001200493

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Azenta, Inc.AZTA · Entity 4724	Director	February 13, 2023	February 15, 2023
MIMEDX GROUP, INC.MDXG · Entity 5271	Director	June 10, 2026	June 12, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Azenta, Inc.

Report date February 13, 2023 · Filed February 15, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
CommonSEC Table I · non-derivative	Direct	3,604	Reported balance After 2023-02-13 transaction · row 1 1 source row Row 1 · 2023-02-13 · Grant · Acquired 3,604 · Balance 3,604 F1: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Filing footnotes · ownership attribution and instrument terms

F1: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

MIMEDX GROUP, INC.

Report date June 10, 2026 · Filed June 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	108,510	Reported balance After 2026-06-10 transaction · row 1 1 source row Row 1 · 2026-06-10 · Grant · Acquired 50,913 · Balance 108,510 F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.

Filing footnotes · ownership attribution and instrument terms

F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ABIOMED INC

Report date December 22, 2022 · Filed December 27, 2022

Section 16 reporting ended · disclosed 2022-12-27. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $0.01 par valueSEC Table I · non-derivative	Direct	0	Reported balance After 2022-12-22 transaction · row 1 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 1 · 2022-12-22 · Disposition to issuer · Disposed 3,255 · Balance 0 F1: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement. F2: Pursuant to the Merger Agreement, each award of restricted stock units, excluding any award of restricted stock units with vesting subject to performance-based conditions ("Company RSU Award"), outstanding as of immediately prior to the effective time of the Merger (the "Effective Time") was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share underlying such Company RSU Award immediately prior to the Effective Time. F3: Reflects the correction of an immaterial error in the balance reported in the reporting person's Form 4 filed on August 12, 2022.
Common Stock, $0.01 par valueSEC Table I · non-derivative	Direct	0	Reported balance After 2022-12-22 transaction · row 2 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 2 · 2022-12-22 · Disposition to issuer · Disposed 11,335 · Balance 0 F1: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the "Merger Agreement"), by and among the Issuer, Johnson & Johnson ("Parent") and Athos Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the "Issuer Share") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the "Cash Amount"), plus (ii) one non-tradeable contingent value right (the "CVR"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement.

F2: Pursuant to the Merger Agreement, each award of restricted stock units, excluding any award of restricted stock units with vesting subject to performance-based conditions ("Company RSU Award"), outstanding as of immediately prior to the effective time of the Merger (the "Effective Time") was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share underlying such Company RSU Award immediately prior to the Effective Time.

F3: Reflects the correction of an immaterial error in the balance reported in the reporting person's Form 4 filed on August 12, 2022.

Mirror Merger Sub 2, LLC

Report date March 01, 2021 · Filed March 03, 2021

Section 16 reporting ended · disclosed 2021-03-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Eaton Vance Corp. Non-voting Common StockSEC Table I · non-derivative	Direct	Reported balance After 2021-03-01 transaction · row 1 1 source row Row 1 · 2021-03-01 · Disposition to issuer · Disposed 23,981 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of October 7, 2020 (the Merger Agreement), by and among Issuer, Morgan Stanley, Mirror Merger Sub 1, Inc. and Mirror Merger Sub 2, LLC, in exchange for $1,750,613.00.
Deferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2021-03-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-03-01 · Disposition to issuer · Disposed 9,372 · Balance 0 F2: Each Deferred Stock Unit is the economic equivalent of one share of non-voting common stock. F3: This Deferred Stock Unit award was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $684,156.00.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.23 · Expires 2022-11-01	Direct	Reported balance After 2021-03-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-03-01 · Disposition to issuer · Disposed 5,680 · Balance 0 F4: This option award, which was granted on November 1, 2012, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $254,310.13.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.76 · Expires 2025-11-02	Direct	Reported balance After 2021-03-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-03-01 · Disposition to issuer · Disposed 7,451 · Balance 0 F5: This option award, which was granted on November 2, 2015, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $270,024.24.
Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.71 · Expires 2024-11-03	Direct	Reported balance After 2021-03-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2021-03-01 · Disposition to issuer · Disposed 5,737 · Balance 0 F6: This option award, which was granted on November 3, 2014, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $208,195.73.
Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2021-03-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-03-01 · Disposition to issuer · Disposed 3,252 · Balance 0 F7: Each Phantom Stock Unit is the economic equivalent of one share of non-voting common stock. F8: This Phantom Stock Unit award, which was granted on November 1, 2017, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $237,396.00.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of October 7, 2020 (the Merger Agreement), by and among Issuer, Morgan Stanley, Mirror Merger Sub 1, Inc. and Mirror Merger Sub 2, LLC, in exchange for $1,750,613.00.

F2: Each Deferred Stock Unit is the economic equivalent of one share of non-voting common stock.

F3: This Deferred Stock Unit award was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $684,156.00.

F4: This option award, which was granted on November 1, 2012, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $254,310.13.

F5: This option award, which was granted on November 2, 2015, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $270,024.24.

F6: This option award, which was granted on November 3, 2014, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $208,195.73.

F7: Each Phantom Stock Unit is the economic equivalent of one share of non-voting common stock.

F8: This Phantom Stock Unit award, which was granted on November 1, 2017, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $237,396.00.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
November 01, 2018 Filed Nov 5, 2018 11:58 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	16	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-015162 · doc4.xml · derivative · entry 4 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,112 Underlying: Eaton Vance Corp. Non-voting Common Stock · 16 shares Expires 2018-11-01 F3 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. The shares of Phantom Stock become payable in cash at the earlier of the second anniversary of the grant date or the date of the non-employee director's termination. F4 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. Read SEC document
November 01, 2018 Filed Nov 5, 2018 11:58 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantDeferred Stock · Derivative	3,077	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-015162 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,077 Underlying: Eaton Vance Corp. Non-voting Common Stock · 3,077 shares Expires not disclosed F1 · security: Each share of Deferred Stock is the economic equivalent of one share of non-voting common stock. F2 · derivative.exercise_date: The shares of Deferred Stock granted on November 1, 2018 become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. F2 · derivative.expiration_date: The shares of Deferred Stock granted on November 1, 2018 become payable in cash based on the non-employee director's election at either (1) the earlier of the second anniversary of the grant date or the date of the non-employee director's termination, or (2) upon the non-employee director's termination. Read SEC document
November 01, 2018 Filed Nov 5, 2018 11:58 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Disposition to issuerEaton Vance Corp. Non-voting Common Stock	2,112	$45.50	$96,096.00	Disclosure SEC source: 0001225208-18-015162 · doc4.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,981 Read SEC document
November 01, 2018 Filed Nov 5, 2018 11:58 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionEaton Vance Corp. Non-voting Common Stock	2,112	$0.00	$0.00	Disclosure SEC source: 0001225208-18-015162 · doc4.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 15, 2018 Filed Aug 16, 2018 13:49 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	12	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-012669 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,096 Underlying: Eaton Vance Corp. Non-voting Common Stock · 12 shares Expires 2018-11-01 F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. The shares of Phantom Stock become payable in cash at the earlier of the second anniversary of the grant date or the date of the non-employee director's termination. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. Read SEC document
August 15, 2018 Filed Aug 16, 2018 13:49 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	17	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-012669 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,811 Underlying: Eaton Vance Corp. Non-voting Common Stock · 17 shares Expires not disclosed F1 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F3 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
August 09, 2018 Filed Aug 10, 2018 20:14 UTC	ABIOMED INC ABMD · Entity 121309	Tax withholdingCommon Stock, $0.01 par value	541	$376.01	$203,421.41	Disclosure SEC source: 0001179110-18-010526 · edgar.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,823 F2 · kind: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards. F2 · shares: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards. Read SEC document
August 08, 2018 Filed Aug 10, 2018 20:14 UTC	ABIOMED INC ABMD · Entity 121309	GrantCommon Stock, $0.01 par value	531	$0.00	$0.00	Disclosure SEC source: 0001179110-18-010526 · edgar.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,364 F1 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 8, 2019; or (b) the date of the Issuer's next annual meeting of stockholders. F1 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 8, 2019; or (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document
May 15, 2018 Filed May 15, 2018 13:52 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	12	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-009328 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,084 Underlying: Eaton Vance Corp. Non-voting Common Stock · 12 shares Expires 2018-11-01 F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. The shares of Phantom Stock become payable in cash at the earlier of the second anniversary of the grant date or the date of the non-employee director's termination. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. Read SEC document
May 15, 2018 Filed May 15, 2018 13:52 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	16	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-009328 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,794 Underlying: Eaton Vance Corp. Non-voting Common Stock · 16 shares Expires not disclosed F1 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F3 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
May 07, 2018 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	Exercise / conversionStock Option (right to buy) · Derivative	13,500	$0.00 Strike: $9.99	$0.00	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · derivative · entry 12 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,500 shares Expires 2020-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. F3 · kind: Exercise of stock options pursuant to reporting owner's 10b5-1 plan. F2 · derivative.exercise_date: This option becomes exerciseable in full on the date set forth in Table II, Column 6. Read SEC document
May 07, 2018 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	300	$351.97	$105,591.00	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 9 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,168 F4 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. Read SEC document
May 07, 2018 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	900	$351.06	$315,953.01	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 8 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,468 F4 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F11 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $350.9600 and $351.2300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
May 07, 2018 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	700	$349.98	$244,986.00	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 7 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,368 F4 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F10 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $349.7900 and $350.4100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
May 07, 2018 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	4,195	$349.07	$1,464,351.17	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 6 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,068 F4 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F9 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $348.5600 and $349.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
May 07, 2018 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	1,500	$348.07	$522,108.00	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 5 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,263 F4 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F8 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $347.8400 and $348.4800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
May 07, 2018 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	3,012	$347.07	$1,045,367.31	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 4 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,763 F4 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F7 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $346.6000 and $347.4600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
May 07, 2018 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	1,664	$346.20	$576,076.80	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,775 F4 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F6 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $345.6500 and $346.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
May 07, 2018 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	1,229	$345.10	$424,132.32	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,439 F4 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F5 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $344.5600 and $345.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
May 07, 2018 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	Exercise / conversionCommon Stock, $0.01 par value	13,500	$9.99	$134,865.00	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Exercise of stock options pursuant to reporting owner's 10b5-1 plan. F3 · shares: Exercise of stock options pursuant to reporting owner's 10b5-1 plan. Read SEC document
February 15, 2018 Filed Feb 16, 2018 14:38 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	11	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-003116 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,072 Underlying: Eaton Vance Corp. Non-voting Common Stock · 11 shares Expires 2018-11-01 F4 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. The shares of Phantom Stock become payable in cash at the earlier of the second anniversary of the grant date or the date of the non-employee director's termination. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. Read SEC document
February 15, 2018 Filed Feb 16, 2018 14:38 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	15	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-003116 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,778 Underlying: Eaton Vance Corp. Non-voting Common Stock · 15 shares Expires not disclosed F1 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. F3 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F3 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
January 16, 2018 Filed Jan 17, 2018 14:37 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionOption (right to buy) · Derivative	11,777	$0.00 Strike: $34.84	$0.00	Disclosure SEC source: 0001225208-18-001096 · doc4.xml · derivative · entry 5 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 11,777 shares Expires 2026-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 16, 2018 Filed Jan 17, 2018 14:37 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionOption (right to buy) · Derivative	4,045	$0.00 Strike: $41.90	$0.00	Disclosure SEC source: 0001225208-18-001096 · doc4.xml · derivative · entry 4 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 4,045 shares Expires 2023-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 16, 2018 Filed Jan 17, 2018 14:37 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	SaleEaton Vance Corp. Non-voting Common Stock	9,490	$60.49	$574,050.10	Disclosure SEC source: 0001225208-18-001096 · doc4.xml · nonDerivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,981 F1 · shares: Shares were sold to cover the exercise cost and tax liability associated with the exercise of a NQ stock option. Read SEC document
January 16, 2018 Filed Jan 17, 2018 14:37 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionEaton Vance Corp. Non-voting Common Stock	4,045	$41.90	$169,485.50	Disclosure SEC source: 0001225208-18-001096 · doc4.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 16, 2018 Filed Jan 17, 2018 14:37 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionEaton Vance Corp. Non-voting Common Stock	11,777	$34.84	$410,310.68	Disclosure SEC source: 0001225208-18-001096 · doc4.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 15, 2017 Filed Nov 15, 2017 14:36 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	13	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-17-017348 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,061 Underlying: Eaton Vance Corp. Non-voting Common Stock · 13 shares Expires 2018-11-01 F1 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. The shares of Phantom Stock become payable in cash at the earlier of the second anniversary of the grant date or the date of the non-employee director's termination. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. Read SEC document
November 09, 2017 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	GiftCommon Stock, $0.01 par value	11,335	$0.00	$0.00	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 11 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 11,335 F12 · kind: This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust. F12 · shares: This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust. Read SEC document
November 09, 2017 Filed May 9, 2018 19:17 UTC	ABIOMED INC ABMD · Entity 121309	GiftCommon Stock, $0.01 par value	11,335	$0.00	$0.00	Disclosure SEC source: 0001179110-18-006498 · edgar.xml · nonDerivative · entry 10 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,833 F12 · kind: This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust. F12 · shares: This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust. Read SEC document
November 02, 2017 Filed Nov 6, 2017 10:49 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionPhantom Stock · Derivative	1,587	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-17-016963 · doc4.xml · derivative · entry 4 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 1,587 shares Expires 2017-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. The shares of Phantom Stock become payable in cash at the earlier of the second anniversary of the grant date or the date of the non-employee director's termination. Read SEC document
November 02, 2017 Filed Nov 6, 2017 10:49 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	10	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-17-016963 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,587 Underlying: Eaton Vance Corp. Non-voting Common Stock · 10 shares Expires 2017-11-02 F1 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. The shares of Phantom Stock become payable in cash at the earlier of the second anniversary of the grant date or the date of the non-employee director's termination. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. Read SEC document
November 02, 2017 Filed Nov 6, 2017 10:49 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Disposition to issuerEaton Vance Corp. Non-voting Common Stock	1,587	$51.04	$81,000.48	Disclosure SEC source: 0001225208-17-016963 · doc4.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,649 Read SEC document
November 02, 2017 Filed Nov 6, 2017 10:49 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionEaton Vance Corp. Non-voting Common Stock	1,587	$0.00	$0.00	Disclosure SEC source: 0001225208-17-016963 · doc4.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 01, 2017 Filed Nov 3, 2017 09:54 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	1,381	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-17-016861 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,381 Underlying: Eaton Vance Corp. Non-voting Common Stock · 1,381 shares Expires not disclosed F1 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F2 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F2 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
November 01, 2017 Filed Nov 3, 2017 09:54 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantOption (right to buy) · Derivative	6,808	$0.00 Strike: $50.67	$0.00	Disclosure SEC source: 0001225208-17-016861 · doc4.xml · derivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808 Underlying: Eaton Vance Corp. Non-voting Common Stock · 6,808 shares Expires 2027-11-01 Read SEC document
November 01, 2017 Filed Nov 13, 2017 10:42 UTC Amendment	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	2,763	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-17-017197 · doc4a.xml · derivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,763 Underlying: Eaton Vance Corp. Non-voting Common Stock · 2,763 shares Expires not disclosed F1 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. F2 · shares: The original Form 4 filed on November 3, 2017 incorrectly reported grants on November 1, 2017 of 1,381 shares of Phantom Stock and 6,808 Stock Options. The actual grant on November 1, 2017 was for 2,763 shares of Phantom Stock. No Stock Options were granted. This amended Form 4 corrects this information to accurately reflect the November 1, 2017 grant. F3 · derivative.exercise_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. F3 · derivative.expiration_date: The shares of Phantom Stock granted on November 1, 2017 become payable in cash upon the non-employee director's termination. Read SEC document
October 30, 2017 Filed Nov 1, 2017 16:09 UTC	ABIOMED INC ABMD · Entity 121309	Exercise / conversionStock Option (right to buy) · Derivative	13,500	$0.00 Strike: $7.67	$0.00	Disclosure SEC source: 0001179110-17-013622 · edgar.xml · derivative · entry 4 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,500 shares Expires 2019-08-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. F3 · kind: Exercise of stock options pursuant to reporting owner's 10b5-1 plan. F3 · shares: Exercise of stock options pursuant to reporting owner's 10b5-1 plan. F2 · derivative.exercise_date: This option becomes exerciseable in full on the date set forth in Table II, Column 6. Read SEC document
October 30, 2017 Filed Nov 1, 2017 16:09 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	2,700	$179.49	$484,613.28	Disclosure SEC source: 0001179110-17-013622 · edgar.xml · nonDerivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,168 F4 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F6 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $179.170 and $179.9700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
October 30, 2017 Filed Nov 1, 2017 16:09 UTC	ABIOMED INC ABMD · Entity 121309	SaleCommon Stock, $0.01 par value	3,664	$178.77	$655,024.27	Disclosure SEC source: 0001179110-17-013622 · edgar.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,868 F4 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F5 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $178.1700 and $179.1100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document
October 30, 2017 Filed Nov 1, 2017 16:09 UTC	ABIOMED INC ABMD · Entity 121309	Exercise / conversionCommon Stock, $0.01 par value	13,500	$7.67	$103,545.00	Disclosure SEC source: 0001179110-17-013622 · edgar.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Exercise of stock options pursuant to reporting owner's 10b5-1 plan. F3 · shares: Exercise of stock options pursuant to reporting owner's 10b5-1 plan. Read SEC document
October 26, 2017 Filed Oct 27, 2017 09:53 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionOption (right to buy) · Derivative	6,420	$0.00 Strike: $24.46	$0.00	Disclosure SEC source: 0001225208-17-016585 · doc4.xml · derivative · entry 5 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 6,420 shares Expires 2021-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 26, 2017 Filed Oct 27, 2017 09:53 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionOption (right to buy) · Derivative	4,902	$0.00 Strike: $28.69	$0.00	Disclosure SEC source: 0001225208-17-016585 · doc4.xml · derivative · entry 4 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 4,902 shares Expires 2020-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 26, 2017 Filed Oct 27, 2017 09:53 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	SaleEaton Vance Corp. Non-voting Common Stock	5,953	$51.08	$304,104.84	Disclosure SEC source: 0001225208-17-016585 · doc4.xml · nonDerivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,649 F1 · shares: Shares were sold to cover the exercise cost and tax liability associated with the exercise of a NQ stock option. Read SEC document
October 26, 2017 Filed Oct 27, 2017 09:53 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionEaton Vance Corp. Non-voting Common Stock	4,902	$28.69	$140,613.87	Disclosure SEC source: 0001225208-17-016585 · doc4.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 26, 2017 Filed Oct 27, 2017 09:53 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionEaton Vance Corp. Non-voting Common Stock	6,420	$24.46	$157,029.99	Disclosure SEC source: 0001225208-17-016585 · doc4.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 28, 2017 Filed Oct 2, 2017 11:07 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionOption (right to buy) · Derivative	6,865	$0.00 Strike: $47.23	$0.00	Disclosure SEC source: 0001225208-17-015488 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Eaton Vance Corp. Non-voting Common Stock · 6,865 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 28, 2017 Filed Oct 2, 2017 11:07 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	SaleEaton Vance Corp. Non-voting Common Stock	6,495	$49.38	$320,695.82	Disclosure SEC source: 0001225208-17-015488 · doc4.xml · nonDerivative · entry 2 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,280 F1 · shares: Shares were sold to cover the exercise cost and tax liability associated with the exercise of a NQ stock option. Read SEC document
September 28, 2017 Filed Oct 2, 2017 11:07 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	Exercise / conversionEaton Vance Corp. Non-voting Common Stock	6,865	$47.23	$324,237.38	Disclosure SEC source: 0001225208-17-015488 · doc4.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 15, 2017 Filed Aug 15, 2017 11:17 UTC	Mirror Merger Sub 2, LLC EV · Entity 141944	GrantPhantom Stock · Derivative	10	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-17-013988 · doc4.xml · derivative · entry 3 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,577 Underlying: Eaton Vance Corp. Non-voting Common Stock · 10 shares Expires 2017-11-02 F1 · security: Each share of Phantom Stock is the economic equivalent of one share of non-voting common stock. The shares of Phantom Stock become payable in cash at the earlier of the second anniversary of the grant date or the date of the non-employee director's termination. F2 · shares: As dividends are paid with respect to Company Non-Voting Common Stock, a number of units of Phantom Stock with a current value equal to the amount of the dividend will be allocated to the account of each non-employee Director with respect to each unit of Phantom Stock Awarded at the time such dividends are paid to the stock holders of the Company. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.